MAP2K7 and neoplasm: The significant and differential association of KRAS mutations with bilaterality/tumour spread and BRAF/ERBB2 mutations with genomic stability suggests that despite all of these gene products being associated with the RAS/MEK/ERK pathway, mutant forms of these genes are not biologically equivalent in this context.